Texto: 
Physical exam unremarkable.Laboratory significant for Hct of 21.   Endoscopy revealed a 2-3 cm ulcerated mass at the gatroesophageal junction
This patient will initially receive adjuvant chemotherapy  (5- fluorouracil ) and radiotherapy.  She will then undergo surgical resection of her tumor followed by additional adjuvant chemotherapy and radiotherapy to prevent recurrence.
CT of chest, abdomen, and pelvis with contrast-  lobular thickening of the lower esophageal wall and luminal wall at the GE junction; no adenopathyPET- no abnormal findingsEsophageal US-T2/T3
Adenocarcinoma of the gastroesophageal junction, no evidence of Barrett esophagus found - Stage: T3N0M0
Malignancy, leiomyoma or benign tumor, Irritation, Inflammation
The patient is a 39 year old female with a chief complaint of worsening solid and liquid dysphagia over a >6 months duration.


Keywords: 
\-\ 39\\ year\\ old\\ female\ \(6\)\
\-\ 3\\ cm\\ ulcerated\\ mass\ \(1\)\
\-\ initially\\ receive\\ adjuvant\\ chemotherapy\ \(1\)\
\-\ additional\\ adjuvant\\ chemotherapy\ \(1\)\
\-\ undergo\\ surgical\\ resection\ \(4\)\
\-\ physical\\ exam\\ unremarkable\ \(0\)\
\-\ barrett\\ esophagus\\ found\ \(0\)\
\-\ abnormal\\ findingsesophageal\\ us\ \(0\)\
\-\ 6\\ months\\ duration\ \(1\)\
\-\ lower\\ esophageal\\ wall\ \(1\)\
\-\ luminal\\ wall\ \(1\)\
\-\ worsening\\ solid\ \(1\)\
\-\ tumor\\ followed\ \(2\)\
\-\ t3n0m0\\ malignancy\ \(0\)\
\-\ t3\\ adenocarcinoma\ \(0\)\
\-\ prevent\\ recurrence\ \(6\)\
\-\ lobular\\ thickening\ \(1\)\
\-\ liquid\\ dysphagia\ \(1\)\
\-\ laboratory\\ significant\ \(0\)\
\-\ ge\\ junction\ \(1\)\
\-\ gatroesophageal\\ junction\ \(2\)\
\-\ gastroesophageal\\ junction\ \(29\)\
\-\ endoscopy\\ revealed\ \(0\)\
\-\ chief\\ complaint\ \(32\)\
\-\ benign\\ tumor\ \(21\)\
\-\ t2\ \(2\)\
\-\ stage\ \(292\)\
\-\ radiotherapy\ \(39\)\
\-\ pelvis\ \(424\)\
\-\ patient\ \(6664\)\
\-\ leiomyoma\ \(85\)\
\-\ irritation\ \(22\)\
\-\ inflammation\ \(200\)\
\-\ hct\ \(1\)\
\-\ fluorouracil\ \(1\)\
\-\ evidence\ \(994\)\
\-\ ct\ \(23117\)\
\-\ contrast\ \(1612\)\
\-\ chest\ \(1434\)\
\-\ adenopathypet\ \(0\)\
\-\ abdomen\ \(661\)\
\-\ 5\ \(8237\)\
\-\ 21\ \(409\)\
\-\ 2\ \(13754\)\
